Golden Arrow Merger Corp. Announces Full Exercise and Closing of the Underwriters’ Over-Allotment Option in Connection with...
May 06 2021 - 8:29PM
Golden Arrow Merger Corp. (the “
Company”) announced today
that the underwriters of its previously announced initial public
offering of units have exercised their over-allotment option in
full, resulting in the issuance of an additional 3,750,000 units at
a public offering price of $10.00 per unit. After giving effect to
the exercise and close of the option, an aggregate of 28,750,000
units have been issued in the initial public offering and an
aggregate of $287,500,000 has been deposited in the Company’s trust
account.
The Company also announced that commencing on May 7, 2021,
holders of the units sold in the Company’s initial public offering
may elect to separately trade shares of the Company’s Class A
common stock and redeemable warrants included in the units. No
fractional warrants will be issued upon separation of the units and
only whole warrants will trade. Those units not separated will
continue to trade on the Nasdaq Capital Market (“Nasdaq”)
under the ticker symbol “GAMCU,” and the Class A common
stock and warrants that are separated will trade on Nasdaq under
the symbols “GAMC” and “GAMCW,” respectively. Holders
of units will need to have their brokers contact Continental Stock
Transfer & Trust Company, the Company's transfer agent, in
order to separate the units into shares of Class A common stock and
redeemable warrants.
The units were initially offered by the Company in an
underwritten offering. BTIG, LLC acted as sole book-running manager
and I-Bankers Securities, Inc. acted as co-manager in the
offering.
A registration statement relating to the securities
became effective on March 16, 2021. The offering
was made only by means of a prospectus, copies of which may be
obtained for free from the U.S. Securities and Exchange Commission
(the "SEC") website at www.sec.gov or by contacting
BTIG, LLC, 65 East 55th Street, New York, NY 10022,
Email: ProspectusDelivery@btig.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the securities of the Company, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
About Golden Arrow Merger Corp.
Golden Arrow Merger Corp. is a blank check company formed as a
Delaware corporation for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses. While
the Company may pursue an acquisition opportunity in any business,
industry, sector, or geography, it intends to initially focus its
search on identifying a prospective target business in the
healthcare or healthcare-related infrastructure industries in the
United States and other developed countries.
Forward-Looking Statements
This press release contains statements that constitute
“forward-looking statements,” including with respect to the
anticipated use of the net proceeds of the Company’s initial public
offering and the Company’s search for an initial business
combination. No assurance can be given that the net proceeds of the
offering will be used as indicated. Forward-looking statements are
subject to numerous conditions, many of which are beyond the
control of the Company, including those set forth in the Risk
Factors section of the Company’s registration statement and
prospectus for the offering filed with the SEC. Copies are
available on the SEC’s website, www.sec.gov. The Company undertakes
no obligation to update these statements for revisions or changes
after the date of this release, except as required by law.
Media Contact: Golden Arrow Merger Corp. Valerie Toomey
info@goldenarrowspac.com
Golden Arrow Merger (NASDAQ:GAMC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Golden Arrow Merger (NASDAQ:GAMC)
Historical Stock Chart
From Oct 2023 to Oct 2024